N/A
Completed N=26
Walking Aids in the Management of Hip Osteoarthritis
Source: ClinicalTrials.gov NCT00506714 ↗Enrolled (actual)
26
Serious AEs
0.0%
Results posted
Sep 2012
Primary outcomePrimary: Gait Velocity — 107.5; 79.7 cm/s
Summary
The purpose of this study is to determine whether or not the use of a nonpharmacologic intervention (single point cane) is effective in the treatment of knee osteoarthritis.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Gait Velocity |
74.5 | — |
| SECONDARY Gait Velocity With a Cane in Hip OA Subjects |
68.7 | — |
| SECONDARY Gait Velocity |
74.5 | — |
Eligibility Criteria
Inclusion Criteria
- hip OA (grades II-IV) of the Kellgren/Lawrence classification
- with pain in one hip for most days of the prior month
- Ability to walk 30 feet without postural sway
- Ability to stand unaided
- Ability to understand verbal instructions
- Ability to give informed consent
Exclusion Criteria
- History of hip or knee trauma or surgery including arthroscopic surgery in the past six months
- Severe obesity (> 300 pounds)
- Neurological disorders that affect lower extremity function such as stroke or peripheral neuropathy, vestibular dysfunction or poor vision
- Injury or amputation to the lower extremity joints
- History of other types of arthritis or fibromyalgia
- Pain from spine, knee, ankle, or foot disease that would interfere with assessment of the hip
- Poor health that would impair compliance or assessment such as shortness of breath with exertion, chest pain
- Foot deformities such as hallux rigidus, valgus deformity of the midfoot, previous ankle arthrodesis
- Greater trochanteric pain syndrome
Data sourced from ClinicalTrials.gov (NCT00506714). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.